CRAACO is guided by a dedicated group of advisors from pharma, healthcare, patients and patient advocacy who are passionate about providing patients with the best possible options. With four years of experience gathering the clinical research and healthcare communities together, CRAACO has the most experience addressing the value, opportunities, and challenges to integrating clinical research as a care option for the benefit of patients.
We hope you can join Elligo CEO John Potthoff, along with 83bar CBO Kate Hermans and Geneoscopy CEO Andrew Barnell, on November 6 at 9:30 a.m. EST for their case study presentation, A Decentralized Trial Conducted Within Healthcare.
This presentation will cover:
• How decentralized trials can lower costs and decrease time to complete clinical trials while increasing quality
• A decentralized trial that involved engineering complicated procedures within healthcare
• Designing appropriate recruitment campaigns to accelerate a decentralized trial